Contrary to Guidelines, 5-ASA Often Prescribed in Pediatric Crohn’s Disease
DENVER — Even though guidelines discourage the use of 5-aminosalicylate (5-ASA) in pediatric Crohn’s disease, a substantial percentage of children are still being treated with the anti-inflammatory agent, which may cause problems down the road, a researcher reported here. Of nearly 700 children diagnosed with Crohn’s disease and treated at specialized centers, 28% were initially […]